They could only experiment on three people because of lack of funds. The big pharma companies declined to participate. "Too risky" I wonder if they are afraid of a real cure, instead of treatments that take months and have to be repeated.
Joan Slonczewski gave a lecture on a similar process at Diversicon. It's complicated. It was another group of three test subjects, but these therapies require modification of each subjects cells -- at least her lecture's did -- where they stole a lot of genetic code from various viri to combat a genetic disease. Chimera come home.
![[identity profile]](https://www.dreamwidth.org/img/silk/identity/openid.png){kind=small}
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
branchandroot
no subject
Date: 2011-08-13 03:26 pm (UTC)Paranoid this a.m., I guess
no subject
Date: 2011-08-13 03:56 pm (UTC)